Bisacodyl
Brand names: Dulcolax
Bisacodyl is a stimulant laxative used for constipation and for bowel preparation before procedures.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It stimulates the enteric nerves of the colon to increase peristalsis and also promotes fluid and electrolyte accumulation in the bowel lumen, softening stool and hastening transit.
Prescribing in practice
- Avoid in intestinal obstruction, ileus, acute abdominal conditions and acute inflammatory bowel disease.
- Abdominal cramps and discomfort are common, and prolonged excessive use can lead to fluid and electrolyte disturbance.
- Oral tablets are enteric coated and should not be taken with milk or antacids, which can cause premature dissolution and gastric irritation.
Monitoring
No routine monitoring is needed for short-term use; with prolonged or high-dose use consider fluid balance and electrolytes, particularly potassium.
Counselling the patient
- Tablets usually work overnight, so they are typically taken at bedtime, whereas suppositories act within about an hour.
- Swallow tablets whole without milk or antacids close to the dose, and maintain a good fluid intake.
- Seek advice if you have severe abdominal pain, vomiting or no bowel movement despite treatment.
Evidence & guidelines
Standard stimulant laxative option (NICE CKS constipation).
Reference: BSG Bowel Preparation Guidelines; SPC Dulcolax; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021